View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Whitworth Luke
(Last) (First) (Middle)
C/O OPTION CARE HEALTH, INC.
3000 LAKESIDE DRIVE, SUITE 300N
(Street)
BANNOCKBURN IL 60015
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/16/2023 		3. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 28,684(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 02/17/2032 Common Stock 8,104 23.96 D
Employee Stock Option (right to buy) 10/21/2024 10/21/2031 Common Stock 24,679 25.75 D
Employee Stock Option (right to buy) (3) 02/23/2031 Common Stock 12,900 18.97 D
Employee Stock Option (right to buy) (4) 03/09/2030 Common Stock 36,092 13.34 D
Explanation of Responses:
1. Includes (i) 4,176 restricted stock units that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026, (ii) restricted stock units that vest as to 50% of the underlying shares of Common Stock on February 23, 2023, and 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025, (iii) 9,372 restricted stock units that vest as to 50% of the underlying shares of Common Stock on each of March 9, 2023 and March 9, 2024, and (iv) 8,544 restricted stock units that vest on October 21, 2024.
2. Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.
3. Stock options that vest as to 50% of the underlying shares of Common Stock on February 23, 2023, and 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025.
4. Stock options that vest as to 50% of the underlying shares of Common Stock on March 9, 2022, and 25% of the underlying shares of Common Stock on each of March 9, 2023 and March 9, 2024.
/s/ Collin Smyser, attorney-in-fact for Mr. Whitworth 01/25/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS

       KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
 appoints each of Michael Shapiro, Collin Smyser, Sarah Kim and
Michael Bavaro signing singly, the undersigned's true
and lawful attorney-in-fact to:

  (i)  execute for and on behalf of the undersigned, in the undersigned's
 capacity as an officer and/or director and/or owner of greater than 10% of the
 outstanding shares of common stock of Option Care Health, Inc., a Delaware
 corporation (the "Company"), Forms 3, 4 and 5 (including any amendments,
 supplements or exhibits thereto) in accordance with Section 16(a) of the
 Securities Exchange Act of 1934 and the rules thereunder;

  (ii)  do and perform any and all acts for and on behalf of the undersigned
 which may be necessary or desirable to complete and execute any such Form 3,
 4 or 5 (including any amendments, supplements or exhibits thereto) and timely
 file such form with the United States Securities and Exchange Commission (the
 "SEC") and any stock exchange or similar authority, including the New York
 Stock Exchange, and including without limitation the filing of a Form ID or
 any other documents necessary or appropriate to enable the undersigned to file
 the Form 3, 4 and 5 electronically with the SEC;

  (iii)  seek or obtain, as the undersigned's representative and on the
 undersigned's behalf, information on transactions in the Company's securities
 from any third party, including brokers, employee benefit plan administrators
 and trustees, and the undersigned hereby authorizes any such person to release
 any such information to each of the undersigned's attorneys-in-fact appointed
 by this Power of Attorney and ratifies any such release of information; and

   (iv)  take any other action of any type whatsoever in connection with the
 foregoing which, in the opinion of such attorney-in-fact, may be of benefit
 to, in the best interest of, or legally required by, the undersigned, it being
 understood that the documents executed by such attorney-in-fact on behalf of
 the undersigned pursuant to this Power of Attorney shall be in such form and
 shall contain such terms and conditions as such attorney-in-fact may approve
 in such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
 and authority to do and perform any and every act and thing whatsoever
 requisite, necessary or proper to be done in the exercise of any of the rights
 and powers herein granted, as fully to all intents and purposes as the
 undersigned might or could do if personally present, with full power of
 substitution or revocation, hereby ratifying and confirming all that such
 attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
 lawfully do or cause to be done by virtue of this power of attorney and the
 rights and powers herein granted.

       The undersigned acknowledges that the foregoing attorneys-in-fact, in
 serving in such capacity at the request of the undersigned, are not assuming,
 nor is the Company assuming, any of the undersigned's responsibilities to
 comply with Section 16 of the Securities Exchange Act of 1934.

       This Power of Attorney shall remain in full force and effect until the
 undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
 undersigned's holdings of and transactions in securities issued by the Company,
 unless earlier revoked by the undersigned in a signed writing delivered to the
 foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
 be executed as of date first written above.


Signed and acknowledged:

/s/ Luke Whitworth